Your browser doesn't support javascript.
loading
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.
Mecenate, Fabrizio; Pellicelli, Adriano M; Barbaro, Giuseppe; Romano, Mario; Barlattani, Angelo; Mazzoni, Ettore; Bonaventura, Maria Elena; Nosotti, Lorenzo; Arcuri, Pasquale; Picardi, Antonio; Barbarini, Giorgio; D'Ambrosio, Cecilia; Paffetti, Amerigo; Andreoli, Arnaldo; Soccorsi, Fabrizio.
Affiliation
  • Mecenate F; Liver Unit San Camillo Forlanini Hospital, Rome, Italy.
BMC Gastroenterol ; 10: 21, 2010 Feb 19.
Article in En | MEDLINE | ID: mdl-20170514
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepacivirus / Hepatitis C, Chronic Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2010 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepacivirus / Hepatitis C, Chronic Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2010 Document type: Article Affiliation country: Italy Country of publication: United kingdom